Douglas Losordo, M.D., FACC, FAHA, Senior Vice President of Clinical Medical and Regulatory Affairs and Chief Medical Officer to present.
- Session: Advances in Adult Stem Cell Research
- Title: Recent Breakthroughs with CD34+ Cell Therapy in Cardiovascular Disease: Insights from Clinical Trials in >700 Patients
- Date and Time: Thursday, April 12, 2018 at 10:55am EST
- Location: Hyatt Regency Boston Hotel, Boston, MA
In addition, Dr. Losordo will act as moderator for panels entitled “Regulatory Challenges in Cell Therapy” and “Revolution in Immunotherapy.” For more information, please visit www.gtcbio.com/conferences/stem-cell-summit.